{
    "ID": "1",
    "NUM_ENREGISTREMENT": "352\/15 F 099\/16",
    "CODE": "15 F 099",
    "DENOMINATION_COMMUNE_INTERNATIONALE": "RIVASTIGMINE TARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_DE_MARQUE": "RESTILON",
    "FORME": "SOLUTION BUV",
    "DOSAGE": "2MG\/ML",
    "COND": "B\/1 FL DE 120ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": null,
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_DENREGISTREMENT": "EL KENDI INDUSTRIE DES MEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_DENREGISTREMENT": "ALGERIE",
    "DATE_DENREGISTREMENT_INITIAL": "2016-12-04",
    "DATE_DENREGISTREMENT_FINAL": "2016-12-04",
    "TYPE": "Ge",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "PRIX_PORTE_SUR_LA_DECISION_DENREGISTREMENT": "PCSU 2907,20 DA",
    "REMBOURSEMENT": null
}